← Leaderboards
Jan Frederik Stevens
Oregon State University
$5,275,226
Attributed
$8,718,378
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2006–23$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$9,060,941 · 11
By mechanism
R01$6,342,976 · 3
S10$1,609,536 · 6
R21$1,108,429 · 2
Top collaborators
- Ryan D Bradley7 shared
- Claudia S Maier7 shared
- Thomas O Metz7 shared
- Adrian Friedrich Gombart6 shared
Most similar at Oregon State University
Same institution · by research overlap
- Ryan D Bradley$4,472,124
- Claudia S Maier$8,451,190
- John E Fowler$4,054,694
- Ha-Yeon Cheong$1,615,710
- Duo Jiang$567,823
Others in their field
Top investigators on “Inflammation”
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
- Sharon L Hillier · Magee-Women'S Hospital Of Upmc$89,523,713
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Randall J Bateman · Washington University$64,707,456
- Peter Scott Heeger · Case Western Reserve University$56,547,884
Research focus
InflammationBiologicalHumulusInflammatoryClinical ResearchInnovationMetabolismBaseMetabolomicsCellsPlasmaAdultBloodInflammatory Disease Of The IntestineResearch PersonnelPredispositionMediatingOralInfectionClinical TrialsGut MicrobiotaMicrobialMolecularResponse
Grant awards (28)
Computation-assisted discovery of bioactive minor cannabinoids from hemp$408,375
R21 · FY2023 · AT · contact PI
Discovery and Biological Signatures of Microbiome-Derived Xanthohumol Metabolites and their Role in Ameliorating Inflammatory Bowel Disease$394,762
R01 · FY2021 · AT · contact PI
CIH Practitioner Mentorship in Translational Clinical Research$95,082
R01 · FY2021 · AT · contact PI
Discovery and Biological Signatures of Microbiome-Derived Xanthohumol Metabolites and their Role in Ameliorating Inflammatory Bowel Disease$27,120
R01 · FY2021 · AT · contact PI
Discovery and Biological Signatures of Microbiome-Derived Xanthohumol Metabolites and their Role in Ameliorating Inflammatory Bowel Disease$385,056
R01 · FY2020 · AT · contact PI
CIH Practitioner Mentorship in Translational Clinical Research$139,600
R01 · FY2020 · AT · contact PI
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and$531,479
R01 · FY2019 · AT
Discovery and Biological Signatures of Microbiome-Derived Xanthohumol Metabolites and their Role in Ameliorating Inflammatory Bowel Disease$365,163
R01 · FY2019 · AT · contact PI
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and$543,239
R01 · FY2018 · AT
Discovery and Biological Signatures of Microbiome-Derived Xanthohumol Metabolites and their Role in Ameliorating Inflammatory Bowel Disease$399,697
R01 · FY2018 · AT · contact PI
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and$388,000
R01 · FY2018 · AT
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and$541,769
R01 · FY2017 · AT
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and$519,719
R01 · FY2016 · AT
Vitamin D, Xanthohumol and Nuclear Receptors: Targeting Immunity, Microbiota and$504,042
R01 · FY2015 · AT
Xanthohumol and Metabolic Syndrome$87,016
R21 · FY2012 · AT · contact PI
Xanthohumol and Metabolic Syndrome$306,604
R21 · FY2011 · AT · contact PI
Triple Quadrupole/Linear Ion Trap LC-MS/MS for LPI$484,410
S10 · FY2010 · RR · contact PI
Xanthohumol and Metabolic Syndrome$306,434
R21 · FY2010 · AT · contact PI
Ascorbylation of Oxidized Lipids and Atherosclerosis$299,298
R01 · FY2010 · HL · contact PI
Ion Mobility Time-of-flight Mass Spectrometry System$440,000
S10 · FY2009 · RR
Ascorbylation of Oxidized Lipids and Atherosclerosis$299,585
R01 · FY2009 · HL · contact PI
Ascorbylation of Oxidized Lipids and Atherosclerosis$299,863
R01 · FY2008 · HL · contact PI
Ascorbylation of Oxidized Lipids and Atherosclerosis$300,134
R01 · FY2007 · HL · contact PI
Hybrid triple quadrupole linear ion trap mass spectrometer$342,563
S10 · FY2006 · RR · contact PI
Ascorbylation of Oxidized Lipids and Atherosclerosis$309,368
R01 · FY2006 · HL · contact PI
HYBRID TRIPLE QUADRUPOLE LINEAR ION TRAP MASS SPECTROMETER$171,282
S10 · FY2006 · RR · contact PI
HYBRID TRIPLE QUADRUPOLE LINEAR ION TRAP MASS SPECTROMETER: CARDIOVASCULAR$137,025
S10 · FY2006 · RR · contact PI
HYBRID TRIPLE QUADRUPOLE LINEAR ION TRAP MASS SPECTROMETER: PROSTATE CANCER$34,256
S10 · FY2006 · RR · contact PI